| Nr. | Numele studiului | Status | Locatia/Locatiile studiului |
| 1 | Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy | Activ, inca nu se recruteaza | Institutul Oncologic „Prof Alexandru Trestioreanu” Busuresti Sectia Oncologie Medicala I, Bucuresti, Romania, 022328Spitalul Clinic „Fundeni” Departament Oncologie Medicala – Gastroenterologie, Bucuresti, Romania, 022328Spitalul Clinic „Coltea” Sectia Oncologie Medicala, Bucuresti, Romania, 030171Institutul Oncologic „Prof. Dr. I. Chiricuta” Cluj Napoca Oncologie Medical, Cluj-Napoca, Romania, 400015S.C Oncolab S.R.L Sectia Oncologie Medicala, Craiova, Romania, 200385Institutul Regional de Oncologie Iasi Clinica de Oncologie Medicala, Iaşi, Romania, 700483Spitalul Clinic Judetean de Urgenta Sibiu Sectia Oncologie Medicala, Sibiu, Romania, 550245S.C ONCOMED S.R.L Departament Oncologie Medicala, Timişoara, Romania, 300239 |
| 2 | A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic) | Activ, inca nu se recruteaza | Spitalul Clinic „Fundeni” Departament Oncologie Medicala – Gastroenterologie, Bucuresti, Romania, 022328Institutul Oncologic „Prof. Dr. I. Chiricuta” Cluj Napoca Oncologie Medicala, Cluj Napoca, Romania, 400015Institutul Regional de Oncologie Iasi Clinica de Oncologie Medicala, Iasi, Romania, 700483 |
| 3 | A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator’s Choice Chemotherapy for the Treatment of Patients With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) | In curs de recrutare | Local Institution, Brasov, Romania, 002200, Contact: Site 0168 Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0076 Local Institution, Constanta, Romania, 900591, Contact: Site 0075 Local Institution, Craiova, Romania, 200347, Contact: Site 0081 Local Institution, Suceava, Romania, 720237, Contact: Site 0089 |
| 4 | Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer | In curs de recrutare | Research Site Bucharest, Romania, 022328 Research Site Cluj-Napoca, Romania, 400015 Research Site Cluj-Napoca, Romania, 400124 Research Site Craiova, Romania, 200347 Research Site Iasi, Romania, 700483 Research Site Timisoara, Romania, 300239 |
(Visited 244 times, 1 visits today)